List of National Health Research Institutes patents

Patents where

Current Assignee

Name

‌

National Health Research Institutes

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11360080 AhR-ROR-γt complex as a biomarker and therapeutic target for autoimmune disease and IL-17A-associated disease	Patent 11360080 was granted and assigned to National Health Research Institutes on June, 2022 by the United States Patent and Trademark Office.	‌ National Health Research Institutes	‌ National Health Research Institutes	United States Patent and Trademark Office	11360080	June 14, 2022
‌ US Patent 7544712 Treatment of coronavirus infection	Patent 7544712 was granted and assigned to National Health Research Institutes on June, 2009 by the United States Patent and Trademark Office.		‌ National Health Research Institutes	United States Patent and Trademark Office	7544712	June 9, 2009
‌ US Patent 11384326 Selective particles transfer from one device to another	Patent 11384326 was granted and assigned to National Health Research Institutes on July, 2022 by the United States Patent and Trademark Office.	‌ National Health Research Institutes	‌ National Health Research Institutes	United States Patent and Trademark Office	11384326	July 12, 2022
‌ US Patent 7507534 Rapid efficacy assessment method for lung cancer therapy	Patent 7507534 was granted and assigned to National Health Research Institutes on March, 2009 by the United States Patent and Trademark Office.		‌ National Health Research Institutes	United States Patent and Trademark Office	7507534	March 24, 2009
‌ US Patent 7342232 Device and method for digitizing pet radiation events	Patent 7342232 was granted and assigned to National Health Research Institutes on March, 2008 by the United States Patent and Trademark Office.		‌ National Health Research Institutes	United States Patent and Trademark Office	7342232	March 11, 2008
‌ US Patent 8229544 Detecting temperature and protein denaturation during thermal therapy	Patent 8229544 was granted and assigned to National Health Research Institutes on July, 2012 by the United States Patent and Trademark Office.		‌ National Health Research Institutes	United States Patent and Trademark Office	8229544	July 24, 2012
‌ US Patent 7199370 Device and method for digitizing gamma ray energy and characterizing peak time and decay time constant without the use of ADC	Patent 7199370 was granted and assigned to National Health Research Institutes on April, 2007 by the United States Patent and Trademark Office.		‌ National Health Research Institutes	United States Patent and Trademark Office	7199370	April 3, 2007
‌ US Patent 7491397 Receptor binding polypeptides	Patent 7491397 was granted and assigned to National Health Research Institutes on February, 2009 by the United States Patent and Trademark Office.		‌ National Health Research Institutes	United States Patent and Trademark Office	7491397	February 17, 2009
‌ US Patent 11623960 Dual-function antibodies targeting VEGFR2 and VEGFR3	Patent 11623960 was granted and assigned to National Health Research Institutes on April, 2023 by the United States Patent and Trademark Office.	‌ National Health Research Institutes	‌ National Health Research Institutes	United States Patent and Trademark Office	11623960	April 11, 2023
‌ US Patent 8485974 Multiple-frequency ultrasonic phased array driving system	Patent 8485974 was granted and assigned to National Health Research Institutes on July, 2013 by the United States Patent and Trademark Office.		‌ National Health Research Institutes	United States Patent and Trademark Office	8485974	July 16, 2013
‌ US Patent 7332502 Phenanthroindolizidine alkaloids	Patent 7332502 was granted and assigned to National Health Research Institutes on February, 2008 by the United States Patent and Trademark Office.		‌ National Health Research Institutes	United States Patent and Trademark Office	7332502	February 19, 2008
‌ US Patent 7528165 Indole compounds	Patent 7528165 was granted and assigned to National Health Research Institutes on May, 2009 by the United States Patent and Trademark Office.		‌ National Health Research Institutes	United States Patent and Trademark Office	7528165	May 5, 2009
‌ US Patent 7534606 Placental stem cell and methods thereof	Patent 7534606 was granted and assigned to National Health Research Institutes on May, 2009 by the United States Patent and Trademark Office.		‌ National Health Research Institutes	United States Patent and Trademark Office	7534606	May 19, 2009
‌ US Patent 8198284 Treatment of neurodegenerative disorders with thiourea compounds	Patent 8198284 was granted and assigned to National Health Research Institutes on June, 2012 by the United States Patent and Trademark Office.		‌ National Health Research Institutes	United States Patent and Trademark Office	8198284	June 12, 2012
‌ US Patent 7449478 Indole compounds	Patent 7449478 was granted and assigned to National Health Research Institutes on November, 2008 by the United States Patent and Trademark Office.		‌ National Health Research Institutes	United States Patent and Trademark Office	7449478	November 11, 2008
‌ US Patent 8716512 Preparation and purification of subunit vaccine for	Patent 8716512 was granted and assigned to National Health Research Institutes on May, 2014 by the United States Patent and Trademark Office.		‌ National Health Research Institutes	United States Patent and Trademark Office	8716512	May 6, 2014
‌ US Patent 7569596 Imidazolamino compounds	Patent 7569596 was granted and assigned to National Health Research Institutes on August, 2009 by the United States Patent and Trademark Office.		‌ National Health Research Institutes	United States Patent and Trademark Office	7569596	August 4, 2009
‌ US Patent 11623951 Antibodies to R-spondin 3	Patent 11623951 was granted and assigned to National Health Research Institutes on April, 2023 by the United States Patent and Trademark Office.	‌ National Health Research Institutes	‌ National Health Research Institutes	United States Patent and Trademark Office	11623951	April 11, 2023
‌ US Patent 7939523 Imidazolidinone and imidazolidinethione derivatives	Patent 7939523 was granted and assigned to National Health Research Institutes on May, 2011 by the United States Patent and Trademark Office.		‌ National Health Research Institutes	United States Patent and Trademark Office	7939523	May 10, 2011
‌ US Patent 7985763 Hepatitis C virus inhibitors	Patent 7985763 was granted and assigned to National Health Research Institutes on July, 2011 by the United States Patent and Trademark Office.		‌ National Health Research Institutes	United States Patent and Trademark Office	7985763	July 26, 2011
‌ US Patent 10172945 Sorbitan polyester conjugates for stabilizing water-in-oil emulsions and delivering controlled release of bioactive agents	Patent 10172945 was granted and assigned to National Health Research Institutes on January, 2019 by the United States Patent and Trademark Office.	‌ National Health Research Institutes	‌ National Health Research Institutes	United States Patent and Trademark Office	10172945	January 8, 2019
‌ US Patent 8734844 Solid phase gold nanoparticle synthesis	Patent 8734844 was granted and assigned to National Health Research Institutes on May, 2014 by the United States Patent and Trademark Office.		‌ National Health Research Institutes	United States Patent and Trademark Office	8734844	May 27, 2014
‌ US Patent 7687504 Pyrrolidine compounds	Patent 7687504 was granted and assigned to National Health Research Institutes on March, 2010 by the United States Patent and Trademark Office.		‌ National Health Research Institutes	United States Patent and Trademark Office	7687504	March 30, 2010
‌ US Patent 8058427 Coumarin compounds and their use for treating cancer	Patent 8058427 was granted and assigned to National Health Research Institutes on November, 2011 by the United States Patent and Trademark Office.		‌ National Health Research Institutes	United States Patent and Trademark Office	8058427	November 15, 2011
‌ US Patent 7396838 Use of 1H-indol-3-yl-2-oxoacetamide compounds	Patent 7396838 was granted and assigned to National Health Research Institutes on July, 2008 by the United States Patent and Trademark Office.		‌ National Health Research Institutes	United States Patent and Trademark Office	7396838	July 8, 2008

...

Results per page:

123 results

0 selected

123 results

0 selected